大动脉狭窄与随后黄斑疾病的可能性之间的关系:全国数据库研究
Chia-Yi Lee1,2,3, Shun-Fa Yang1,4, Elsa Lin-Chin Mai2,5,6,7
1Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
Diagnostics (Basel, Switzerland)
|March 28, 2025
概括
大动脉狭窄 (AS) 与患有AMD和RVO等黄斑疾病的风险增加有关. 随着AS持续时间的延长,这些危及视力的疾病的风险越高.
科学领域:
- 眼科医生 眼科 眼科
- 心脏病学 心脏病学
- 视网膜疾病 视网膜疾病
背景情况:
- 大动脉狭窄 (AS) 是一种重要的心血管疾病.
- 黄斑疾病对视力构成重大威胁.
- 在AS和黄斑病发病率之间的关系需要进一步调查.
研究的目的:
- 探索大动脉狭窄 (AS) 和随后各种黄斑疾病的发展之间的关联.
- 量化AS患者与没有AS患者的黄斑疾病风险.
主要方法:
- 一项使用TrinetX数据库的回顾性队列研究.
- 将421,860名具有AS的参与者与同等数量的非AS对照进行匹配.
- 考克斯比例危险回归分析以评估结果,包括与年龄相关的黄斑变性 (AMD),视网膜血管封闭 (RVO),视网膜膜 (ERM) 和中央血清胆色素变性 (CSC).
主要成果:
- 与非AS队列相比,AS队列的AMD,RVO,ERM和CSC发病率显著更高 (所有p <0.05).
- 在AS组中,所有研究的黄斑疾病的累积概率显著增加.
- 敏感性分析证实AS组中AMD发展的风险明显更高.
结论:
- 大动脉狭窄占用与患黄斑疾病的风险增加有关.
- 黄斑疾病发展的风险与大动脉狭窄的持续时间有积极的相关性.
更多相关视频
相关概念视频
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...


